According to Bionano Genomics
's latest financial reports the company has $0.10 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.10 B | -9.98% |
2022-12-31 | $0.11 B | -54.84% |
2021-12-31 | $0.25 B | 551.8% |
2020-12-31 | $38.44 M | 122.1% |
2019-12-31 | $17.31 M | 4.77% |
2018-12-31 | $16.52 M | 1516.87% |
2017-12-31 | $1.02 M | -80.53% |
2016-12-31 | $5.24 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
PerkinElmer
PKI | $2.46 B | 2,315.54% | ๐บ๐ธ USA |
Quanterix QTRX | $0.32 B | 215.37% | ๐บ๐ธ USA |
Precipio PRPO | $1.5 M | -98.53% | ๐บ๐ธ USA |